Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
CanImGuide Therapeutics AB
AB
In liquidation
Org 5567002117
Malmö
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2006 · 20 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
CanImGuide Therapeutics AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
MR
Marc Richard Tullgren
Liquidator
Liquidator
2023
ÅC
Åsa Cecilia Andersson Eneberg
Chief Auditor
Chief Auditor
2021
Former (2)
CM
Carl Magnus Schultz
Chief Executive Officer
Chief Executive Officer
2020 – 2021
JE
Jan Erik Alenfall
Chief Executive Officer
Chief Executive Officer
2022 – 2022
Board of directors
Non-executive oversight
Name
Role
Member since
Former (11)
LG
Lars Georg Emanuel Karlsson
Board of Directors
Board of Directors
2020 – 2021
JP
Jan Peter Ernst Christensson
Deputy Board Member
Deputy Board Member
2021 – 2023
NK
Nils Kai Fritiof Siegbahn
Chairman
Chairman
2020 – 2022
NJ
Nils Jan Ragnar Nilsson
Board of Directors
Board of Directors
2020 – 2021
JE
Jan Erik Alenfall
Board of Directors
Board of Directors
2022 – 2022
DG
Derek Gregory Batcheller
Board of Directors
Board of Directors
2020 – 2022
JS
Jackie Sarah McKen
Board of Directors
Board of Directors
2020 – 2021
ÅC
Åsa Cecilia Andersson Eneberg
Deputy Board Member
Deputy Board Member
2020 – 2021
LG
Leif Gunnar Håkansson
Board of Directors
Board of Directors
2020 – 2021
CJ
Christopher John Tovey
Board of Directors
Board of Directors
2020 – 2021
LO
Lars Olof Hedbys
Deputy Board Member
Deputy Board Member
2021 – 2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on CanImGuide Therapeutics AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network